Sector revisions Biogen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 06/02/2026 GMT			5-day change	1st Jan Change
201.18 ^USD	+8.53%		+11.84%	+14.31%

02-06	Stifel Nicolaus Adjusts Biogen PT to $214 From $202, Maintains Buy Rating	MT
02-06	Biogen Inc., Q4 2025 Earnings Call, Feb 06, 2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Visibility	Nbr of analysts
BIOGEN INC.		28
REGENERON PHARMACEUTICALS, INC.		26
CSL LIMITED		16
UCB		19
SAMSUNG BIOLOGICS CO.,LTD.		26
INCYTE CORPORATION		22
INNOVENT BIOLOGICS, INC.		24
MODERNA, INC.		20
SWEDISH ORPHAN BIOVITRUM AB		11
INTRA-CELLULAR THERAPIES, INC.	-	-
ALTEOGEN INC.		4
BRIDGEBIO PHARMA, INC.		20
BIOMARIN PHARMACEUTICAL INC.		23
AVIDITY BIOSCIENCES, INC.		11
AXSOME THERAPEUTICS, INC.		20
GRIFOLS, S.A.		12
KRYSTAL BIOTECH, INC.		10
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	1
3SBIO INC.		11
Average		17
Weighted average by Cap.		20